HSCS
HEALTHCAREHeart Test Laboratories Inc
$1.81-0.22 (-10.84%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving HSCS Today?
No stock-specific AI insight has been generated for HSCS yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.80$6.47
$1.81
Fundamentals
Market Cap$6M
P/E Ratio—
EPS$-4.49
Dividend Yield—
Dividend / Share—
ROE-3.8%
Profit Margin—
Debt / Equity—
Trading
Volume74K
Avg Volume (10D)—
Shares Outstanding3.2M
HSCS News
20 articles- HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™Yahoo Finance·May 5, 2026
- HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders MeetingYahoo Finance·Apr 14, 2026
- HeartSciences’ MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System CategoryYahoo Finance·Mar 25, 2026
- HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor MeetingsYahoo Finance·Mar 24, 2026
- Investor Summit Announces Q1 Presenter Line Up (Presentations 3/25, 1-on-1s 3/26)Yahoo Finance·Mar 20, 2026
- HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business UpdateYahoo Finance·Mar 16, 2026
- University of West England Adopts HeartSciences’ MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference CenterYahoo Finance·Feb 5, 2026
- Cibolo Health Designates HeartSciences’ MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent HospitalsYahoo Finance·Jan 29, 2026
- HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business UpdateYahoo Finance·Dec 15, 2025
- HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ DeviceYahoo Finance·Dec 15, 2025
- HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1Yahoo Finance·Dec 11, 2025
- HeartSciences Inc. (HSCS) May Find a Bottom Soon, Here's Why You Should Buy the Stock NowYahoo Finance·Oct 21, 2025
- HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial ResultsYahoo Finance·Sep 11, 2025
- Presenting on Emerging Growth Conference 85 Day 1 on August 20; Register to live streamYahoo Finance·Aug 19, 2025
- HeartSciences Announces Conference Participation and Investor WebinarYahoo Finance·Aug 15, 2025
- HeartSciences Provides Business Update and Reports Fiscal 2025 Financial ResultsYahoo Finance·Jul 24, 2025
- HeartSciences recesives FDA BDD for Aortic Stenosis ECG algorithmYahoo Finance·Jun 5, 2025
- HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic StenosisYahoo Finance·Jun 4, 2025
- Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences’ Patent Portfolio and IP ValueYahoo Finance·Jun 3, 2025
- HeartSciences signs first MyoVista Insights platform customerYahoo Finance·May 30, 2025
All 20 articles loaded
Price Data
Open$0.00
Previous Close$2.03
Day High$0.00
Day Low$0.00
52 Week High$6.47
52 Week Low$1.80
52-Week Range
$1.80$6.47
$1.81
Fundamentals
Market Cap$6M
P/E Ratio—
EPS$-4.49
Dividend Yield—
Dividend / Share—
ROE-3.8%
Profit Margin—
Debt / Equity—
Trading
Volume74K
Avg Volume (10D)—
Shares Outstanding3.2M
About Heart Test Laboratories Inc
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company is headquartered in Southlake, Texas.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—